Anion-switchable supramolecular gels for controlling pharmaceutical crystal growth. by Foster,  J.A. et al.
Durham Research Online
Deposited in DRO:
27 March 2013
Version of attached file:
Accepted Version
Peer-review status of attached file:
Peer-reviewed
Citation for published item:
Foster, J.A. and Piepenbrock, M.O.M. and Lloyd, G.O. and Clarke, N. and Howard, J.A.K. and Steed, J.W.
(2010) ’Anion-switchable supramolecular gels for controlling pharmaceutical crystal growth.’, Nature
chemistry., 2 (12). pp. 1037-1043.
Further information on publisher’s website:
http://dx.doi.org/10.1038/nchem.859
Publisher’s copyright statement:
Additional information:
Use policy
The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for
personal research or study, educational, or not-for-profit purposes provided that:
• a full bibliographic reference is made to the original source
• a link is made to the metadata record in DRO
• the full-text is not changed in any way
The full-text must not be sold in any format or medium without the formal permission of the copyright holders.
Please consult the full DRO policy for further details.
Durham University Library, Stockton Road, Durham DH1 3LY, United Kingdom
Tel : +44 (0)191 334 3042 — Fax : +44 (0)191 334 2971
http://dro.dur.ac.uk
 1 
Anion-switchable supramolecular gels for controlling 
pharmaceutical crystal growth 
Jonathan A. Foster, Marc-Oliver M. Piepenbrock, Gareth O. Lloyd, Nigel Clarke, Judith A. 
K. Howard and Jonathan W. Steed* 
Abstract 
The use of low molecular weight supramolecular gels as a medium for the growth of 
molecular crystals is described for the first time. Growth of a range of crystals of 
organic compounds including pharmaceuticals was achieved in bis(urea) gels. Low 
molecular weight supramolecular gelators allow access to an unlimited range of 
solvent systems in contrast to conventional aqueous gels. A detailed study of 
carbamazepine crystal growth in four different bis(urea) gelators, including a 
metallogelator is reported. The crystallization of a range of other drug substances, 
namely sparfloxacin, piroxicam, theophylline, caffeine, ibuprofen, acetaminophen 
(paracetamol), sulindac and indomethacin was also achieved in supramolecular gel 
media without cocrystal formation. In many cases crystals can be conveniently 
recovered from the gels by using supramolecular anion-triggered gel dissolution, 
however crystals of substances that themselves bind to anions are dissolved by 
them. Overall supramolecular gel phase crystallization offers an extremely versatile 
new tool in pharmaceutical polymorph screening. 
 
 
Gel media have been utilized for over a century for the growth of inorganic, organic and 
protein crystals.1-5 The improved physical characteristics of the resulting crystals (better 
optical quality, larger size and fewer defects) are usually ascribed to the suppression of 
convection currents, sedimentation and nucleation afforded by the viscous gel 
environment.6-7 In many instances the gel is thought to act as an inert matrix within which 
crystal growth occurs, however in some cases, the gel structure has been shown to 
influence the polymorphism, enantiomorphism and habit of crystals.2 Occasionally gel 
fibres may become incorporated into the crystal, giving rise to composite materials.8 
Conventional gels are formed using polymeric or clay-like materials such as gelatine, 
agarose, polyacrylamide or silica.1,9 More recently, a new class of low molecular weight 
gelators (LMWGs) has emerged.10-12 The supramolecular nature of such systems gives 
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them a potential inherent advantage in that their formation is readily reversible. This sol-gel 
transition can be triggered by a range of stimuli such as changes in temperature, pH, 
sonication, irradiation or, as in the present work, addition of a chemical trigger in the form 
of anions.13-15 Moreover, the chemically diverse nature of LMWG means that almost any 
solvent can be gelled. A diverse range of chemical species form gels including surfactants, 
sugars, fatty acids, amino acids, bis(ureas), and others, in a variety of solvents.10,13 
However, the potential of LMWG’s as a medium for crystal growth is largely unexplored.16-
18 with the exception of some elegant work on the use of LMWG’s for the growth of calcium 
carbonate19 and other inorganic minerals,20 as part of studies on biomineralization. 
The reversible nature of supramolecular gels can be utilized to allow easy recovery 
of crystals. In contrast, conventional hydrogels are limited to water as a solvent and 
removal of the gel may involve either acid hydrolysis or heating, both of which may also 
dissolve the crystals. The diverse array of chemical functionalities that can be introduced 
in small molecule gelators allows for tuning of interactions between the gel and growing 
crystal. LMWG are generally readily synthesized and hence, depending on the system, are 
relatively inexpensive, particularly if required on a large scale. In this communication we 
aim to show proof of principle for the growth and recovery of organic crystals, from anion-
triggered supramolecular gels,21 and to explore the potential of this medium for influencing 
crystal growth and form, particularly in active pharmaceutical ingredients (APIs) for which 
crystal habit and polymorphism is a key economic and formulation problem.22  
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Four bis(urea) gelators (1–4) with different spacers and end groups and varying 
solubility were investigated to demonstrate their potential to act as crystallisation media for 
molecular organic compounds. Compounds 2, and 4 have been reported previously.23-24 
Novel compounds 1 and 3 were prepared by standard methods as detailed in the 
supplementary information. Gelators 1 – 3 were chosen because they reliably form gels in 
a number of solvents ranging from aqueous systems to toluene. The fibrous nature of the 
gels is evidenced by SEM images of the dried xerogels (Figure 1a,b). Compound 4 is a 
metallogelator which forms blue coloured gels with substoichiometric amounts of CuCl2 in 
methanol:water.23 Between them, these gelators can gel a range of solvents, at different 
temperatures (Tgel), and with a different critical gelator concentration (CGC). This class of 
compound has the potential to form the basis of a library of gelators which will allow the 
selection of gel properties and specific functionalities to match the compound and 
crystallisation conditions of interest. The synthetic versatility of these gelators could also in 
principle allow the incorporation of tailored heteronucleating functionality. While we focus 
upon bis(urea) compounds, the concepts outlined herein equally apply to any LMWG. 
Crystallisation experiments were undertaken using a range of organic compounds of 
both drug and non-drug species in parallel in both gel and solution media. We undertook 
an initial screen using candidate compounds 2-hydroxy benzyl alcohol (HBA, 5), Aspirin 
(ASP, 6), carbamazepine (CBZ, 7), 1-(3-methylsulfanyl-phenyl)-3-pyridin-2-yl-urea (SPU, 
8) and 1,3-bis(m-nitrophenyl)urea (NPU, 9). We then carried out a detailed study on CBZ 
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with all gelators, and a follow up study on gelator 3 with a much wider range of 
pharmaceutical compounds. 
For the initial screen HBA was chosen because it forms a co-crystal25 as well as a pure 
phase and hence might exhibit further polymorphism. ASP is an example of a very 
common drug substance that shows little polymorphism and its two closely related forms 
have been the subject of recent controversy.26-27 In contrast CBZ, an anticonvulsant, 
serves as a model compound for many groups engaged in the study of crystal 
polymorphism.28-32 There are four known polymorphs of CBZ as well as a number of co-
crystals. Recently the fourth form was grown using a polymer heteronucleus.33  Details of 
the forms relevant to this paper are shown in table 1.28 The two urea derivatives were 
included because they bear the same functional groups as the gelators themselves and 
hence might potentially interfere with gelation or be templated by the gelators. Both 1,3-
bis(m-nitrophenyl)urea (NPU) and 1-(3-methylsulfanyl-phenyl)-3-pyridin-2-yl-urea (SPU) 
are also highly polymorphic.34-35 Results on CBZ crystallisation proved to be the most 
diverse and hence this substrate was studied in detail with all gelators. Experiments on the 
remaining compounds, along with a larger and more diverse set of pharmaceuticals 
focussed on 2 and particularly 3. 
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Table 1. Solvent-free polymorphs and selected solvated forms of CBZ. 
 
Form Space 
group 
Habit Stability 
order  
Crystallisation 
method 
I Triclinic 
P 1  
Needle 2 Melt 
II Trigonal 
R 3  
Needle 4 Rapid cooling (5ºC) 
from EtOH 
III Monoclinic 
P21/c 
Block 1 Slow cooling (25ºC) 
from EtOH 
IV Monoclinic 
C2/c 
Prism 3 Heteronucleation  
Dihydrate Monoclinic 
P21/c 
Needle n/a Recrystalisation 
from wet ethanol  
Acetone/ 
DMSO 
solvate 
Triclinic 
P 1  
n/a n/a Evaporation from 
solvent 
 
 
Gel-Drug Interactions 
In crystallising drug molecules from supramolecular gels it is important to establish 
whether the presence of the drug molecule has any effect on the gelation process. This 
aspect was studied using compound 1 and carbamazepine. Compound 1 is a versatile 
gelator, forming transparent gels in a variety of apolar solvents, consistent with the 
lipophilic triethoxysilane moiety. For CBZ crystal growth, toluene and CHCl3/toluene 
solvent mixtures dissolve both gelator and crystallisation substrate in the sol state and 
form a gel upon cooling. The typical solid-like rheological properties of the pure gels were 
confirmed by stress-sweep rheometry where the storage modulus (G′) proved to be ca. 1.5 
orders of magnitude larger than the loss modulus (G′′) consistent with solid-like behaviour 
(Figure 2a). The relatively large value of G′ obtained confirms that 1 forms strong gels.10 
The rheological properties of 1 were also examined in the presence of CBZ in order to 
confirm and quantify the gelation in the presence of the crystallisation substrate. CBZ had 
essentially no effect on the magnitude of the storage and loss moduli of the gel, however, 
interestingly the presence of CBZ (one percent by weight) resulted in a marked increase 
by ca. one order of magnitude in the yield stress. This effect is in direct contrast to anion 
binding by bis(urea) gels in which the competition between anion binding and gelator self-
association results in marked anion-dependent decreases in gel strength and yield 
stress.24 The CBZ does, however, lower the gel-sol transition temperature (Tgel; see 
supplementary material Figure S1). NMR titration experiments showed only very weak 
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apparent binding of CBZ to 1 with log K11 = 0.84(8) in CDCl3 and a similar (albeit less 
precise) value in toluene at 70oC above the Tgel. VT NMR spectroscopic experiments show 
that the gelator has a marked effect on the chemical shift of CBZ which is likely to be 
linked to the disruption of CBZ dimer formation28 in solution (see supplementary data). 
Because of its gelation ability the host itself is also likely to undergo significant self-
association and hence the competition between both gelator and CBZ aggregation and 
gelator-CBZ binding results in a low overall apparent binding constant. We therefore 
conclude that the increased yield stress may not be a result of specific binding of the CBZ 
to the gelator, but could arise from the physical support of the gel by solid CBZ crystals. 
This support can be visualised by examination of Fig. 1c which shows the xerogel of 1 in 
which CBZ crystals have grown.  
The influence of acetate anions on the gelation of 1 was also probed by stress-sweep 
rheometry. Acetate was chosen since it is strongly bound by ureas and previous work on 2 
has shown that acetate induces the most significant reduction in gel strength.24 Anion 
addition was carried out on 10 mL samples of 1 in toluene in a concentric cylinder couette 
with addition of 100 μL of MeCN, in which a varying amount of tetrabutylammonium (TBA) 
acetate was dissolved. Consistent with previous work, acetate binding brings about a 
significant weakening of the gel both in terms of G′ and yield stress (Figure 2b). Addition of 
one molar equivalent of acetate is sufficient to completely dissolve the gel. The acetonitrile 
was required for solubility reasons, and addition of the same volume of pure acetonitrile 
without anion does not significantly influence the gel strength. Thus addition of acetate 
anions represents a feasible way to conveniently break down the gel matrix and hence 
retrieve crystalline material formed within the gel.  
Crystallisation from solutions containing one weight percent of CBZ was realised in 
toluene gels of different concentrations of 1 (Figure 3). The drug and the gelator in each 
case were warmed in the solvent and the sample allowed to cool resulting in the formation 
of a clear, transparent gel over ca. five minutes. Crystals of CBZ form typically 8-12 h after 
gelation. Control crystallisations of CBZ under identical conditions without gelator were 
undertaken in parallel. The polymorphic form of the resulting CBZ crystals was analysed 
by single crystal and/or XRPD (supplementary material). In both gel and reference 
samples at all concentrations studied, the kinetically stable needle-like form II appeared 
first. Over a period of 2 days, conversion to the thermodynamically favourable form III was 
observed in the reference samples. This process is significantly slowed down in the gel 
matrix. The reasons for this retardation are unclear but may relate to the much more 
limited convection in the gel samples, slowing down dissolution of the kinetic form (Figure 
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3c). Although no unusual polymorph progression or crystal habit were detected, crystals 
grown inside the gelator network exhibited a tendency to more well-defined crystal faces 
and larger sizes, in some cases up to 20-30 times the size of the reference samples 
(Figure 3d). 
The formation of form II can be completely avoided in a mixed solvent system of 
CHCl3:toluene 1:9 v/v. CBZ and 1 were dissolved in the chloroform with heating. After 
cooling of the solution the addition of toluene results in immediate formation of a rigid gel. 
Crystals of CBZ form III are produced 1-2 days after gelation. Crystallisation is faster in the 
non-gel reference sample and occurs after ca. 1-12 h. For all samples the crystals were 
smaller than in the comparable pure toluene gels, but again crystals obtained from the gels 
tend to grow to larger sizes (Figure 3). Crystal growth results on CBZ are summarised in 
Table 2. 
Recovery of the CBZ crystals grown in the gel phase was readily achieved by anion-
switching. Adding excess TBA acetate as a solid on top of the crystal-containing gel leads 
to rapid dissolution of the gel. From the resulting solution the crystals can be easily 
recovered by filtration. There was no visible degradation of the crystalline sample 
observed by optical microscopy or by X-ray crystallography. This facile breakdown of the 
surrounding gel network is a distinct advantage of LMWGs in comparison to polymer gels 
such as silica.  
 
Table 2. Crystallisation of CBZ in gels of 1 – 3. 
Solvent[a] Crystal forms in 
pure solvent[b] 
Crystal forms 
from gel 1[b] 
Crystal forms 
from gel 2[b] 
Crystal forms 
from gel 3[b] 
Toluene[c] II and/or III II transform to III II and/or III II and/or III 
MeCN:Toluene II and/or III n/a[e] III II and/or III 
CHCl3:Toluene II and/or III II transform to III n/a[f] II and/or III 
Ethyl Acetate II n/a[e] III II 
Acetone No crystals[d] n/a[e] Acetone solvate n/a[e] 
MeOH:H2O
[c] Dihydrate n/a[e] Dihydrate n/a[e] 
DMSO:H2O
[c] Dihydrate n/a[e] n/a[e] I 
[a] Crystallization performed at the same concentration, heating and cooling rates for 
samples of gel and pure solvent. [b] Gels of 2 are 0.1% by weight and of 3 are 1% by 
weight [c] Crystals not retrieved by dissolving the gel with anions [d] Crystallization of the 
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acetone solvate structure occurs upon further super-saturation by evaporation or addition 
of more CBZ [e] no gelation in this solvent. [f] CBZ retards gelation. 
Crystallization of CBZ from other Gels 
Analogous CBZ crystallization experiments were undertaken using gelators 2 and 3, 
which are particularly versatile in their ability to gel a wide range of solvents. Results are 
summarised in Table 2 and selected photographs are given in the supplementary 
information (Figure S3). Gel characterisation data for 2 has been reported previously24 
SEM data of a xerogel of 3 is shown in Fig. 1b and rheometry and additional SEM data is 
given in the supplementary information (Figures S4 and S5). In contrast to 1, gel formation 
by 2 in solutions containing chloroform was found to be retarded by the presence of CBZ. 
Other solvents gelled successfully, although at high concentrations of CBZ in 1:9 
CHCl3:toluene samples of 3 formed only partial gels. TBA acetate was found to break 
down gels of both 2 and 3 in all cases except for the pure toluene gels, where the acetate 
salt is insufficiently soluble, or the aqueous gels where the anion binding is apparently too 
weak to destroy the gel. Figure 4 shows an example of the use of acetate to recover a 
single crystal of CBZ form III grown in a 1:9 CHCl3:toluene gel of 3. 
 
As observed with 1, the toluene gels of 2 and 3 resulted in a mixture of needles of form 
II and blocks of form III. By adjusting the concentration of CBZ it proved possible to grow 
either form; higher concentrations of CBZ results in form II needles, lower concentrations 
give form III blocks. Varying the ratio of co-solvent to toluene had a similar effect with more 
CHCl3 or acetonitrile requiring higher concentrations of CBZ to induce crystal growth and 
growth of form II. In 1:9 v/v acetonitrile:toluene mixtures, only form III blocks were 
observed with slightly higher concentrations of CBZ required to induce crystal growth in 
the gel samples of 3 (>20mg/ml) compared with solution (>15mg/ml). Some of the crystals 
showed different morphology to the normal equant shape and were elongated block 
shaped.2,36 These crystals proved to be twinned, explaining their different morphology.37-38 
In ethyl acetate solutions in the absence of gel, form II grew rapidly before gradually 
converting to form III over several days. In gels of 3, form II was also produced, with 
nucleation appearing to occur on the glass and crystals growing into the gel. No evidence 
of conversion to form III was observed even after several months. In contrast, 
crystallisation from ethyl acetate gels of 2 resulted in the isolation of CBZ as the 
thermodynamic form III even at high concentrations of CBZ (50mg/mL).  
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Other forms of carbamazepine were also encountered. Acetone gels of 2 containing 50 
mg of CBZ after two weeks formed a large single crystal characterised as the triclicinic 
acetone solvate.39-40 Parallel experiments in pure acetone did not produce any crystals. In 
this case, the gel induces crystallisation at lower saturation than the level required for a 
pure solvent crystallisation.  
 Crystallisation of CBZ in MeOH:H2O (8:2) gels of 2 at 0.1% by weight containing 50mg 
of CBZ and parallel reference crystallisation without gelator at the same concentration of 
CBZ both proved to be the monohydrate form of CBZ and were similar in size and shape 
to that from the pure solvent crystallisation.31-32  
In DMSO:water solution in the absence of gel, CBZ formed long, needle like crystals (at 
concentrations in excess of >30g/ml) shown to be pure carbamazepine dihydrate by 
XRPD.28  At low CBZ concentrations no crystal growth was observed in the gels of 2 and 
3.  However, at higher concentrations clumps of very fine crystals formed inside the gel of 
3 exhibiting a powder diffraction pattern corresponding to the relatively unusual CBZ form I 
(supplementary data Figure S6). Form I is the high temperature form of CBZ and is 
normally produced from the melt at 170 ºC. It has also been shown that dehydration of the 
dihydrate can lead to form I under conditions of low humidity.41 The formation of form I in 
the gel under the same conditions that give the dihydrate from solution is a surprising 
result and suggests that the LMWG can have a significant effect on crystal form. IR 
spectroscopic experiments carried out on the wet samples confirmed that a pure form I 
rather than the dihydrate is formed in the gel phase. 
 
Crystallization of Other Substrates 
In addition to the detailed work on the highly polymorphic CBZ, we also undertook a 
range of crystallisation and control experiments on ASP, HBA, SPU and NPU with gelators 
1 – 3. Aspirin was crystallised from a gel of 2 with 50mg mL-1 of ASP at 0.3% by weight 
gelator in MeCN. Crystallisation occurred after one week (Figure S7). An equally 
concentrated solution of ASP in MeCN does not to crystallise under the same conditions 
suggesting that the gel can be used to induce crystallisation. The crystal form proved to be 
the conventional form I. Crystals of HBA were successfully grown from both toluene gels of 
3 and toluene solution and proved to be the known polymorph.42 The crystals obtained 
from the gel were significantly larger, however, with better developed and more regular 
faces (Figure S8). 
The urea derivative SPU crystallised or precipitated from a wide range of gels of 
gelators 1 – 3 in a range of solvents: toluene, ethyl acetate, DMSO and methanol. Solution 
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phase methods give a variety of polymorphs I – IV depending on conditions,35 while gels 
generally give the most thermodynamically stable form IV.  
The other urea derivative, NPU has three concomitant polymorphs, designated as α, β 
and δ. Growth on siloxane SAMs also recently revealed a fourth polymorph and a hydrate 
form is known.43 There are few reliable means to crystallise these forms free of one 
another with the exception of growth on Au-thiol SAMs,44 although slurry methods and fast 
cooling from a supersaturated acetic acid solution were found to be effective at producing 
pure β form.34  Crystallisation of NPU from gels of 2 in MeCN, ethyl acetate, CHCl3 and 
MeOH:H2O was successful but resulted in no control over crystal form. In general the 
yellow prism α form was found at the air/gel interface and the white needle β form within 
the gel matrix in the CHCl3, ethyl acetate and MeCN gels.  Interestingly in the case of ethyl 
acetate gel phase crystallisation gave a distinctive needle shaped morphology, while from 
solution plate-shaped crystals are obtained. The MeOH:H2O gels gave the hydrate form at 
most concentrations although the needle morphology, β form was also observed in more 
concentrated samples.  
Attempts to recover NPU crystals by adding acetate anion as the TBA salt to the gels 
resulted in the dissolution of both the gel and also the crystals in the cases of gels in 
MeCN, ethyl acetate and CHCl3. The gels and crystals of NPU from MeOH:H2O are 
unaffected by the addition of acetate. We suspected that this dissolution results from a 
specific anion-NPU interaction. Solution phase 1H NMR spectroscopic titration confirmed 
that NPU binds strongly to acetate with binding constant log β11 = 3.7(1) in acetonitrile, and 
the host:anion species is more soluble in the solvents used therefore leading to the rapid 
dissolving of any crystalline material. Hence the anion-recovery method is likely to be 
limited to compounds that do not themselves compete with the urea gels for anion binding.  
  
Scope for Crystallistion of Drug Substances 
 Compound 3 is a particularly versatile gelator and we decided to focus attention on 
the breadth of the technique using this compound. Gel-phase and parallel solution phase 
crystallisations were carried out for the following pharmaceutical compounds: sparfloxacin, 
piroxicam, theophylline, caffeine, ibuprofen, acetaminophen (paracetamol), sulindac and 
indomethacin. Experiments were carried out under empirically determined conditions 
designed to bring about crystallisation in the following solvents: 1:9 CH3CN:toluene, 1:9 
CHCl3:toluene, ethyl acetate, 1:1 DMSO:H2O and 3:2 MeOH:H2O. All of these solvent 
mixture form thermoreversible gels with 3, and the first three break down upon the addition 
of acetate anion. The substrates were chosen as commonly available drug substances 
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that represent a wide range of structures and functional group types and are either 
polymorphic, form hydrates or otherwise exhibit interesting crystal packing. The results of 
these experiments are tabulated in the supplementary material (Table S1). Of the 40 
combinations tested, gel formation was observed in all but 7 cases. In 19 cases gels 
formed in the presence of drug substances were at least as strong and of similar 
appearance to the native gels. In 14 cases gels appeared weaker, leaked solvent or 
appeared disrupted by the presence of the drug substance. The high solubility of many of 
the compounds meant that often the concentration of drug molecules was equivalent to, or 
greater than, that of the gelator. In 8 cases no crystallisation occurred from either the gel 
or solution phases over a period of 3 weeks. Crystallisation was found to occur in solution 
but not the gel on 6 instances. In many cases the crystals obtained from both gel and 
solution were the same form and of similar appearance, although some different 
morphologies were noted. A particularly interesting difference in gel phase and solution 
crystallisation behaviour occurs in the anti-inflammatory drug piroxicam (supplementary 
data Figure S9). Piroxicam has three anhydrous forms and a hydrate which are readily 
distinguished by IR spectroscopy.45 Crystallisation from 1:9 acetonitrile:toluene gels of 3 
produced fast growing, needle-like form II in the gel and large block shaped crystals of the 
slow growing form I. In 1:9 chloroform:toluene gels a clump of form II was obtained from 
solution and at the gel surface, whilst blocks of form I were obtained from the bulk of the 
gel.  In ethyl acetate the gel was partially disrupted by the growth of several clumps of form 
II. In DMSO:water, the yellow blocks of the hydrate was identified from solution whilst the 
kinetic form II was recovered from the gel. In methanol:water, small yellow blocks of the 
piroxicam hydrate were seen dispersed throughout the gel systems and on the bottom of 
the corresponding solution. Addition of TBA-acetate led to the dissolution of the crystals as 
well as the gel and samples were extracted for analysis manually. 
 
Crystallisation in a Metallogelator 
In order to demonstrate the versatility of the LMWG approach to crystallisation we also 
studied one substrate (CBZ) with metallogelator 4 which gels in methanol the presence of 
copper(II) halides.23 Crystal growth of CBZ from copper(II) chloride / 4 in 1:1 v/v 
MeOH:water was studied in parallel with gelator-free reference samples. Under these 
conditions 4 forms clear blue gels after the addition of 0.4 – 0.7 equivalents of CuCl2 2H2O 
with brief sonication.46 In all cases gelation was rapid and occurred long before any visible 
crystallisation. Figure 5 shows CBZ crystallisation in the metallogel of 4 after 1 week. 
Remarkably, there is a clear change of crystal habit as compared to the needle-like CBZ 
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hydrate crystals grown in the reference samples. Unit cell determination by single crystal 
X-ray diffraction, however, confirmed this material to be the dihydrate form of CBZ. The 
presence of the labile copper(II) does not result in the isolation of any copper-CBZ 
coordination complexes, although complexation could be an issue for other drugs that are 
more able to ligate the metal centre. In the absence of complex formation, however, 
metallogelators offer an added dimension to the possible options for gel tuning. 
Interestingly, the difference in habit between gel and solution-grown CBZ dihydrate is 
dependent on the amount of copper salt added in the formation of the metallogel. At 0.3 
equivalents of CuCl2, gelation is incomplete, but crystals are clearly shorter than the 
reference samples. With the addition of 0.4 equivalents of the copper chloride complete 
gelation is achieved, and only small crystals are observed. At higher concentrations of the 
metal ion, the formation of long blade-like structures was observed (0.5 equivalents), as 
well as small daughter platelets growing from a central strut (0.6 equivalents) and tree-like 
growths (0.7 equivalents). Recently, oriented attachment growth has led to similar 
appearing metal nanostructures in a surrounding polymer matrix.47-49 One possible 
explanation for the formation of these morphologies is that the amount of copper salt 
influences the gel strength23 and hence rate of convection within the gel. This factor in turn 
influences the degree of nucleation with the result that daughter crystals nucleating on a 
parent CBZ needle become predominant over spontaneous nucleation. SEM micrographs 
(Figure 6) reveal what we believe is early stages of CBZ growth inside the gel and show 
crystals encased by the fibrous matrix. Frequently daughter crystals growing on a large 
central mother crystals are observed, similar in appearance to the larger structures 
observed under the optical microscope. It appears that the gel fibre network “chokes off” 
regions on the central crystal, perhaps restricting crystal surface area and leaving only 
certain regions available for further growth to occur.  
 
Conclusion 
We have demonstrated the use of LMWGs as a medium for organic crystal growth. The 
supramolecular nature of these gels allows for the facile recovery of crystals upon the 
addition of acetate anion without damage to the crystals. Although the effectiveness of 
anion-triggered reversal of gel formation is limited by solvent and the ability of the 
crystalline substrate itself to interact with the anion, gelators can be designed which 
respond to a variety of external stimuli. The ability of LMWGs to gel a wide range of 
solvents allows for detailed screening of compounds. LMWGs may act as an inert matrix, 
slowing down crystallisation and leading to larger, more uniform crystals and inhibiting the 
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conversion of metastable polymorphs. In some cases crystallisation was found to occur in 
the gel but not in solution, whilst in others nucleation required higher levels of 
supersaturation in the gel phase. No gelator-substrate co-crystals were observed 
suggesting effective phase separation between the rapidly forming gel and the slower 
growing substrate crystals. This important observation indicates the general applicability of 
these systems. Clear differences in crystal habit have been seen in the gel phase 
compared with solution and in some cases the gel-phase crystallisation results in the 
formation of different polymorphs compared to the parallel solution phase experiments.  
The vast body of literature on supramolecular gels provides a library of gelators which can 
be chosen to match the crystallisation conditions of interest. The diversity of this class of 
gelator also allows for tuning of interactions between gel and solute. Supramolecular gels 
could find application as an important tool within the context of polymorph screening 
methodologies that are routinely applied at several stages of the drug development 
pipeline and work is in progress on new API materials in collaboration with industry. The 
high quality single crystals that result from gel phase crystallisations are of great potential 
use in macromolecular crystallography where crystal quality, particularly in synchrotron 
work on small samples, is of paramount importance. 
 
Methods 
Gel phase crystallisations were carried out by weighing the appropriate amount of 
substrate (1-5 wt%) and gelator (0.1-1 wt%) in a vial and adding a suitable solvent from a 
stock solution. The sealed vial was then heated until both solids were fully dissolved and 
the mixture was then allowed to cool to room temperature. In each case the gel is formed 
over a period of a few minutes whilst crystallisation takes place over tens of minutes to 
weeks. Where possible, recovery of the crystals was achieved by adding a measured 
amount of acetate as the TBA salt to break down the gels, followed by filtration of the 
resulting solution and washing with water or diethyl ether. Polymorph were identified from 
their characteristic solid state IR spectra (PE Spectrum 100) or where crystal size 
permitted, from the unit cell dimensions of a number of representative single crystals 
(Bruker 6000) or by comparing experimental X-ray powder diffraction patterns (D5000) 
with those calculated from the known single crystal coordinates. Rheology was carried out 
in a concentric cylinder couette on a 10 mL scale using a TA Instruments AR2000 
Rheometer with a standard-size double concentric cylinders geometry and a gap of 1000 
m for all samples. 
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Figure 1 SEM images of xerogels of 1 and 3 obtained from drying a 1 weight % gel in 
toluene. (a) compound 1 (scale bar = 1 m), (b) compound 3 showing a helical twist in the 
fibres arising from the molecular chirality (scale bar 100 nm), (c) xerogel of 1 containing 
crystals of CBZ (scale bar = 10 m) showing the much smaller size of the gel fibres 
compared to the CBZ crystals that the gel is surrounding. The fibrous structure of the gels 
in each case is clearly evident.  
a b c 
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Figure 2 Stress sweep rheology of gelator 1. (a) In toluene with and without CBZ (1 
wt%) showing that the gel is not disrupted by the introduction of CBZ and indeed exhibits a 
higher yield stress. (b) In toluene with 100 μL of MeCN with varying amounts of 
tetrabutylammonium acetate showing the anion-induced weakening and eventual 
dissolution of the gel. 
 
 
 
a b c d 
a 
b 
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Figure 3 CBZ crystals of grown in solutions or gels of 1. a) Form III in 1 weight% of 1 
in toluene, b) Form III from toluene without gelator (40x magnification), c) forms II (mass of 
needles) and III (red circles) in 1 weight% of 1 in toluene (7x magnification), d) form III in 6 
weight% of 1 in toluene (40x magnification), e) Form III in 1 weight% of 1 in 1:9 v/v 
CHCl3:toluene, f) Form III in 1:9 v/v CHCl3:toluene without gelator (25x magnification), c) 
form III in 1 weight% of 1 in 1:9 v/v CHCl3:toluene (7x magnification), d) form III in 6 
weight% of 1 in 1:9 v/v CHCl3:toluene (25x magnification). 
 
 
 
Figure 4 Recovery of a single crystal of CBZ form III by acetate anion triggered gel 
dissolution of a 1:9 CHCl3:toluene gel of gelator 3. A single large CBZ crystal is grown 
in the gel. The gel is then dissolved by addition of acetate anion. The crystal can be redily 
recovered by filtration or manual extraction and mounted for an experiment such as single 
crystal X-ray crystallography. 
 
 
e f g h 
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Figure 5 Optical microscopy of CBZ (1 weight%) grown in a metallogel medium 
along with control experiments showing the effect of the gel. (a) CBZ from 1:1 
MeOH:water reference crystallization from solution, (b) with 0.3 equivalents of CuCl2 
present showing that the copper salt alone does not significantly affect the crystal 
morphology, (c) with 1 weight% of 4 showing the gelator alone does not significantly affect 
the crystal morphology, (d-h) in metallogels of 4 / CuCl2 with (d) 0.3, (e) 0.4, (f) 0.5, (g) 0.6 
and (h) 0.7 equivalents of CuCl2 showing the change in morphology according to the 
strength and composition of the gel. 
 
 
Figure 6 SEM images of CBZ in metallogels of 4 with CuCl2, showing crystals of 
carbamazepine grown within the metallogel. (a) The large needle-shaped crystals are 
parent crystals of CBZ and their surface is predominantly covered by gel fibres. (b) In 
some cases carbamazepine daughter crystals are clearly visible nucleating on the parent 
needles being encased by the gel fiber matrix. (c) and (d) show a close up image of the 
daughter crystals. The gel fibres covering the surface of the parent crystal are also visible. 
(scale bar = 1 m). 
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Summary for Table of Contents 
Supramolecular gels based on small molecule gelators are effective media for the growth 
of novel forms of organic crystals including pharmaceutical compounds. The gels/sol 
transition may be triggered by molecular recognition with anions allowing facile recovery of 
the crystals. 
 
